605507 国邦医药
已收盘 09-14 15:00:00
资讯
新帖
简况
每周股票复盘:国邦医药(605507)将召开2026年半年度业绩说明会
证券之星 · 09-13 03:24
每周股票复盘:国邦医药(605507)将召开2026年半年度业绩说明会
国邦医药(605507)披露2026年半年度业绩说明会安排,9月10日股价上涨2.23%
证券之星 · 09-10
国邦医药(605507)披露2026年半年度业绩说明会安排,9月10日股价上涨2.23%
每周股票复盘:国邦医药(605507)累计回购1.45%股份
证券之星 · 09-06
每周股票复盘:国邦医药(605507)累计回购1.45%股份
股市必读:国邦医药新发布《国邦医药关于股份回购进展公告》
证券之星 · 09-03
股市必读:国邦医药新发布《国邦医药关于股份回购进展公告》
国邦医药(605507)披露股份回购进展公告,9月1日股价上涨2.8%
证券之星 · 09-01
国邦医药(605507)披露股份回购进展公告,9月1日股价上涨2.8%
每周股票复盘:国邦医药(605507)回购股份1.43%耗资1.72亿
证券之星 · 08-09
每周股票复盘:国邦医药(605507)回购股份1.43%耗资1.72亿
8月7日国邦医药涨5.40%,鹏华优质治理LOF基金重仓该股
证券之星 · 08-07
8月7日国邦医药涨5.40%,鹏华优质治理LOF基金重仓该股
国邦医药涨5.40%,西南证券二日前给出“买入”评级
证券之星 · 08-07
国邦医药涨5.40%,西南证券二日前给出“买入”评级
西南证券:给予国邦医药买入评级
证券之星 · 08-05
西南证券:给予国邦医药买入评级
股市必读:国邦医药新发布《2026-032 国邦医药关于股份回购进展公告》
证券之星 · 08-05
股市必读:国邦医药新发布《2026-032 国邦医药关于股份回购进展公告》
国邦医药(605507)披露股份回购进展公告,8月3日股价下跌1.35%
证券之星 · 08-03
国邦医药(605507)披露股份回购进展公告,8月3日股价下跌1.35%
国邦医药(605507)2026年中报简析:增收不增利
证券之星 · 08-02
国邦医药(605507)2026年中报简析:增收不增利
国邦医药(605507)6月30日股东户数2.09万户,较上期增加3.89%
证券之星 · 08-01
国邦医药(605507)6月30日股东户数2.09万户,较上期增加3.89%
国邦医药(605507)披露2026年半年度报告,7月31日股价下跌0.37%
证券之星 · 07-31
国邦医药(605507)披露2026年半年度报告,7月31日股价下跌0.37%
国邦医药(605507.SH)发布半年度业绩,归母净利润3.41亿元,同比下降25.07%
智通财经 · 07-31
国邦医药(605507.SH)发布半年度业绩,归母净利润3.41亿元,同比下降25.07%
每周股票复盘:国邦医药(605507)累计回购1.32%股份
证券之星 · 07-05
每周股票复盘:国邦医药(605507)累计回购1.32%股份
国邦医药(605507)披露股份回购进展公告,7月2日股价上涨1.88%
证券之星 · 07-02
国邦医药(605507)披露股份回购进展公告,7月2日股价上涨1.88%
每周股票复盘:国邦医药(605507)回购股份达1.07%
证券之星 · 06-28
每周股票复盘:国邦医药(605507)回购股份达1.07%
国邦医药(605507)披露回购公司股份比例达1%暨回购进展公告,6月24日股价下跌0.99%
证券之星 · 06-24
国邦医药(605507)披露回购公司股份比例达1%暨回购进展公告,6月24日股价下跌0.99%
每周股票复盘:国邦医药(605507)子公司投2.5亿参与基金
证券之星 · 06-20
每周股票复盘:国邦医药(605507)子公司投2.5亿参与基金
加载更多
公司概况
公司名称:
国邦医药集团股份有限公司
所属行业:
医药制造业
上市日期:
2021-08-02
主营业务:
国邦医药集团股份有限公司的主营业务是医药原料药和制剂、关键医药中间体、动物保健品的研发、生产与销售。公司的主要产品是抗生素类药、心血管系统类药、呼吸系统类药、泌尿系统类药、抗肿瘤类药、还原剂系列产品、高级胺系列产品、兽用抗生素类动保原料药产品、兽用抗虫杀虫药类动保原料药产品、马波沙星、沙拉沙星、地克珠利、环丙氨嗪、加米霉素。公司先后荣获“中国化学制药行业工业企业综合实力百强企业”、全国工商联医药业商会“中国医药工业百强企业”、“优秀院士专家工作站”、第一批浙江省制造业单项冠军企业等荣誉称号。
发行价格:
32.57
{"stockData":{"symbol":"605507","market":"SH","secType":"STK","nameCN":"国邦医药","latestPrice":16.12,"timestamp":1789369201000,"preClose":15.69,"halted":0,"volume":4924080,"delay":0,"changeRate":0.0274,"floatShares":782000000,"shares":782000000,"eps":0.9032,"marketStatus":"已收盘","change":0.43,"latestTime":"09-14 15:00:00","open":15.82,"high":16.24,"low":15.7,"amount":78881400,"amplitude":0.0344,"askPrice":16.13,"askSize":392,"bidPrice":16.12,"bidSize":30,"shortable":0,"etf":0,"ttmEps":0.9032,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"adjPreClose":15.69,"symbolType":"stock","openAndCloseTimeList":[[1789349400000,1789356600000],[1789362000000,1789369200000]],"highLimit":17.26,"lowLimit":14.12,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":782352900,"isCdr":false,"pbRate":1.5,"roa":"--","peRate":17.847653,"roe":"3.96%","epsLYR":1.48,"committee":-0.508999,"marketValue":12612000000,"turnoverRate":0.0063,"status":0,"floatMarketCap":12612000000},"requestUrl":"/m/hq/s/605507/","defaultTab":"news","newsList":[{"id":"2667500614","title":"每周股票复盘:国邦医药(605507)将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2667500614","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667500614?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:24","pubTimestamp":1789241054,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘,国邦医药报收于15.69元,较上周的15.58元上涨0.71%。本周,国邦医药9月11日盘中最高价报16.17元。本周关注点公司公告汇总:国邦医药将于2026年09月17日召开2026年半年度业绩说明会。公司公告汇总国邦医药集团股份有限公司将于2026年09月17日13:00-14:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会,介绍公司经营成果及财务状况。会后可通过上证路演中心查看会议情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666564570","title":"国邦医药(605507)披露2026年半年度业绩说明会安排,9月10日股价上涨2.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666564570","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666564570?lang=zh_cn&edition=full","pubTime":"2026-09-10 17:44","pubTimestamp":1789033463,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘,国邦医药报收于16.04元,较前一交易日上涨2.23%,最新总市值为125.49亿元。该股当日开盘15.72元,最高16.06元,最低15.51元,成交额达7982.08万元,换手率为0.64%。公告显示,国邦医药集团股份有限公司将于2026年09月17日13:00-14:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会,介绍公司经营成果及财务状况。投资者可于2026年09月10日至09月16日16:00前通过上证路演中心网站或公司邮箱info@gbgcn.com提交问题。会后可通过上证路演中心查看会议情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000031999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366591","title":"每周股票复盘:国邦医药(605507)累计回购1.45%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366591","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366591?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:32","pubTimestamp":1788636732,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,国邦医药报收于15.58元,较上周的15.32元上涨1.7%。本周,国邦医药9月4日盘中最高价报15.71元。国邦医药当前最新总市值121.89亿元,在化学制药板块市值排名37/149,在两市A股市值排名1516/5214。截至2026年8月31日,公司已累计回购股份11,372,116股,占总股本的1.45%,回购最高价为16.27元/股,最低价为14.35元/股,已支付总金额175,111,913.45元。上述回购进展符合相关规定及方案要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664195845","title":"股市必读:国邦医药新发布《国邦医药关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664195845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664195845?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:13","pubTimestamp":1788372791,"startTime":"0","endTime":"0","summary":"公司公告汇总:截至2026年8月31日,国邦医药已累计回购股份11,372,116股,占总股本1.45%,支付金额175,111,913.45元。公司公告汇总国邦医药关于股份回购进展公告国邦医药集团股份有限公司于2026年5月29日召开董事会,审议通过以集中竞价交易方式回购股份的方案,回购资金总额为1亿元至2亿元,用于员工持股计划或股权激励,回购价格不超过23元/股,实施期限为2026年5月30日至2027年5月29日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300001994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664574348","title":"国邦医药(605507)披露股份回购进展公告,9月1日股价上涨2.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664574348","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664574348?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:48","pubTimestamp":1788274095,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘,国邦医药报收于15.44元,较前一交易日上涨2.8%,最新总市值为120.8亿元。该股当日开盘14.99元,最高15.52元,最低14.95元,成交额达9144.05万元,换手率为0.76%。近日,国邦医药发布《关于股份回购进展公告》。上述回购进展符合相关规定及方案要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658673435","title":"每周股票复盘:国邦医药(605507)回购股份1.43%耗资1.72亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2658673435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658673435?lang=zh_cn&edition=full","pubTime":"2026-08-09 01:40","pubTimestamp":1786210822,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,国邦医药报收于16.2元,较上周的16.24元下跌0.25%。本周,国邦医药8月3日盘中最高价报16.39元。国邦医药当前最新总市值126.74亿元,在化学制药板块市值排名39/149,在两市A股市值排名1487/5205。本周关注点公司公告汇总:国邦医药已回购股份11,183,416股,占总股本的1.43%,支付金额172,287,559.45元。上述回购进展符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657615764","title":"8月7日国邦医药涨5.40%,鹏华优质治理LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657615764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657615764?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:38","pubTimestamp":1786091923,"startTime":"0","endTime":"0","summary":"证券之星消息,8月7日国邦医药涨5.40%,收盘报16.2元,换手率2.02%,成交量15.84万手,成交额2.53亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共6家,其中持有数量最多的公募基金为鹏华基金的鹏华优质治理LOF。鹏华优质治理LOF目前规模为8.55亿元,最新净值1.2994,较上一交易日下跌0.6%,近一年上涨3.62%。鹏华优质治理LOF的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700027923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657061571","title":"国邦医药涨5.40%,西南证券二日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2657061571","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657061571?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:38","pubTimestamp":1786091909,"startTime":"0","endTime":"0","summary":"今日国邦医药涨5.40%,收盘报16.2元。2026年8月5日,西南证券研究员徐卿,赵磐发布了对国邦医药的研报《2026年中报点评:营收稳健增长,利润短期承压,动保与创新驱动新引擎显现》,该研报对国邦医药给出“买入”评级。研报中预计2026-2028年EPS分别为1.23元、1.52元、1.75元,对应动态PE分别为13/11/9倍,维持“买入”评级。国邦医药个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700027919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","600369"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657547389","title":"西南证券:给予国邦医药买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2657547389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657547389?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:55","pubTimestamp":1785934518,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司徐卿,赵磐近期对国邦医药进行研究并发布了研究报告《2026年中报点评:营收稳健增长,利润短期承压,动保与创新驱动新引擎显现》,给予国邦医药买入评级。最新盈利预测明细如下:该股最近90天内共有4家机构给出评级,买入评级3家,增持评级1家;过去90天内机构目标均价为21.0。本文数据来源于西南证券股份有限公司,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500041458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600369","605507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657637565","title":"股市必读:国邦医药新发布《2026-032 国邦医药关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657637565","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657637565?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:46","pubTimestamp":1785869172,"startTime":"0","endTime":"0","summary":"公司公告汇总:截至2026年7月31日,国邦医药已累计回购股份11,183,416股,占总股本1.43%,支付金额172,287,559.45元。公司公告汇总2026-032 国邦医药关于股份回购进展公告国邦医药集团股份有限公司于2026年5月29日召开董事会,审议通过以集中竞价交易方式回购股份的方案,回购资金总额为1亿元至2亿元,回购价格不超过23元/股,回购期限为2026年5月30日至2027年5月29日,用途为员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656737743","title":"国邦医药(605507)披露股份回购进展公告,8月3日股价下跌1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656737743","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656737743?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:38","pubTimestamp":1785767896,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘,国邦医药报收于16.02元,较前一交易日下跌1.35%,最新总市值为125.33亿元。该股当日开盘16.0元,最高16.39元,最低15.43元,成交额达9829.91万元,换手率为0.79%。近日,国邦医药发布《关于股份回购进展公告》。截至2026年7月31日,公司已累计回购股份11,183,416股,占总股本的1.43%,回购最高价为16.27元/股,最低价为14.35元/股,已支付总金额172,287,559.45元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588311","title":"国邦医药(605507)2026年中报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588311","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656588311?lang=zh_cn&edition=full","pubTime":"2026-08-02 06:01","pubTimestamp":1785621671,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期国邦医药发布2026年中报。根据财报显示,国邦医药增收不增利。截至本报告期末,公司营业总收入31.42亿元,同比上升3.84%,归母净利润3.41亿元,同比下降25.07%。去年的净利率为13.6%,算上全部成本后,公司产品或服务的附加值高。持有国邦医药最多的基金为鹏华优质治理LOF,目前规模为8.55亿元,最新净值1.2875,较上一交易日上涨1.27%,近一年上涨4.16%。本文数据来源于国邦医药2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200001244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656318235","title":"国邦医药(605507)6月30日股东户数2.09万户,较上期增加3.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656318235","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656318235?lang=zh_cn&edition=full","pubTime":"2026-08-01 17:02","pubTimestamp":1785574922,"startTime":"0","endTime":"0","summary":"证券之星消息,近日国邦医药披露,截至2026年6月30日公司股东户数为2.09万户,较3月31日增加781.0户,增幅为3.89%。在化学制药行业个股中,国邦医药股东户数低于行业平均水平,截至6月30日,化学制药行业平均股东户数为3.6万户。从股价来看,2026年3月31日至2026年6月30日,国邦医药区间跌幅为18.03%,在此期间股东户数增加781.0户,增幅为3.89%。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080100012771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655362996","title":"国邦医药(605507)披露2026年半年度报告,7月31日股价下跌0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655362996","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655362996?lang=zh_cn&edition=full","pubTime":"2026-07-31 22:15","pubTimestamp":1785507347,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘,国邦医药报收于16.24元,较前一交易日下跌0.37%,最新总市值为127.05亿元。该股当日开盘16.2元,最高16.36元,最低16.01元,成交额达9481.16万元,换手率为0.75%。近日,国邦医药集团股份有限公司披露《2026年半年度报告》。经营活动产生的现金流量净额为454,949,533.71元,同比上升342.23%。加权平均净资产收益率为3.96%,较上年同期减少1.65个百分点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100041749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655579613","title":"国邦医药(605507.SH)发布半年度业绩,归母净利润3.41亿元,同比下降25.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655579613","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655579613?lang=zh_cn&edition=full","pubTime":"2026-07-31 18:18","pubTimestamp":1785493084,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国邦医药 披露2026年半年度报告,报告期公司实现营收31.42亿元,同比增长3.84%;归属于上市公司股东的净利润3.41亿元,同比下降25.07%;扣非净利润3.21亿元,同比下降26.46%;基本每股收益0.44元。上半年,公司持续加强科研攻关,创新业务不断取得突破。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1474726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"国邦医药(605507.SH)发布半年度业绩,归母净利润3.41亿元,同比下降25.07%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["605507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649622692","title":"每周股票复盘:国邦医药(605507)累计回购1.32%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2649622692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649622692?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:52","pubTimestamp":1783194732,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,国邦医药报收于15.76元,较上周的14.7元上涨7.21%。本周,国邦医药7月3日盘中最高价报15.95元。6月29日盘中最低价报14.34元,股价触及近一年最低点。国邦医药当前最新总市值123.3亿元,在化学制药板块市值排名40/149,在两市A股市值排名1638/5203。截至2026年6月30日,公司已累计回购股份10,357,275股,占总股本的1.32%,已支付总金额159,885,933.94元,回购均价区间为14.35元/股至16.14元/股。上述回购进展符合相关法规及公司方案要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648065695","title":"国邦医药(605507)披露股份回购进展公告,7月2日股价上涨1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648065695","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648065695?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:46","pubTimestamp":1782985601,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘,国邦医药报收于15.68元,较前一交易日上涨1.88%,最新总市值为122.67亿元。该股当日开盘15.47元,最高15.82元,最低15.4元,成交额达8235.34万元,换手率为0.67%。国邦医药于近日披露《关于股份回购进展公告》。截至2026年6月30日,公司已累计回购股份10,357,275股,占总股本的1.32%,已支付总金额159,885,933.94元,回购均价区间为14.35元/股至16.14元/股。上述回购进展符合相关法规及公司方案要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200030175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646315335","title":"每周股票复盘:国邦医药(605507)回购股份达1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646315335","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646315335?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:13","pubTimestamp":1782587590,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,国邦医药报收于14.7元,较上周的15.22元下跌3.42%。本周,国邦医药6月24日盘中最高价报15.74元。6月26日盘中最低价报14.66元,股价触及近一年最低点。国邦医药当前最新总市值115.01亿元,在化学制药板块市值排名37/150,在两市A股市值排名1693/5206。截至2026年6月24日,公司已累计回购股份8,401,562股,占总股本的1.07%,成交最高价为16.14元/股,最低价为14.99元/股,已支付总金额130,855,228.28元。上述进展符合相关法规及公司回购方案要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645118838","title":"国邦医药(605507)披露回购公司股份比例达1%暨回购进展公告,6月24日股价下跌0.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645118838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645118838?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:35","pubTimestamp":1782311714,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘,国邦医药报收于15.05元,较前一交易日下跌0.99%,最新总市值为117.74亿元。该股当日开盘15.55元,最高15.74元,最低15.01元,成交额达7564.08万元,换手率为0.63%。近日,国邦医药发布《关于回购公司股份比例达1%暨回购进展公告》。截至2026年6月24日,公司已累计回购股份8,401,562股,占总股本的1.07%,成交最高价为16.14元/股,最低价为14.99元/股,已支付总金额130,855,228.28元。上述进展符合相关法规及公司回购方案要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400044150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644407065","title":"每周股票复盘:国邦医药(605507)子公司投2.5亿参与基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2644407065","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644407065?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:09","pubTimestamp":1781896192,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,国邦医药报收于15.22元,较上周的16.18元下跌5.93%。本周,国邦医药6月15日盘中最高价报16.47元。本周关注点公司公告汇总:全资子公司拟以2.5亿元认购光明国邦基金50%份额,布局高端医药制造与大健康领域。公司公告汇总:国邦医药已回购股份642.5万股,占总股本0.82%,支付金额超1亿元。截至2026年6月16日,公司已累计回购股份6,425,182股,占总股本的0.82%,已支付金额100,934,682元,回购价格区间为15.27元/股至16.14元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000001897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789402087450,"stockEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.0032},{"period":"3month","weight":-0.0303},{"period":"6month","weight":-0.2277},{"period":"1year","weight":-0.0335},{"period":"ytd","weight":-0.0892}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"国邦医药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20855人(较上一季度增加3.89%)","perCapita":"37513股","listingDate":"2021-08-02","address":"浙江省绍兴市新昌县省级高新技术产业园区兴梅大道60号","registeredCapital":"78235万元","survey":" 国邦医药集团股份有限公司的主营业务是医药原料药和制剂、关键医药中间体、动物保健品的研发、生产与销售。公司的主要产品是抗生素类药、心血管系统类药、呼吸系统类药、泌尿系统类药、抗肿瘤类药、还原剂系列产品、高级胺系列产品、兽用抗生素类动保原料药产品、兽用抗虫杀虫药类动保原料药产品、马波沙星、沙拉沙星、地克珠利、环丙氨嗪、加米霉素。公司先后荣获“中国化学制药行业工业企业综合实力百强企业”、全国工商联医药业商会“中国医药工业百强企业”、“优秀院士专家工作站”、第一批浙江省制造业单项冠军企业等荣誉称号。","listedPrice":32.57},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国邦医药(605507)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国邦医药(605507)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国邦医药,605507,国邦医药股票,国邦医药股票老虎,国邦医药股票老虎国际,国邦医药行情,国邦医药股票行情,国邦医药股价,国邦医药股市,国邦医药股票价格,国邦医药股票交易,国邦医药股票购买,国邦医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国邦医药(605507)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国邦医药(605507)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}